Chemical Structure : IMU-935
CAS No.: 2299252-72-3
货号: PC-20040Not For Human Use, Lab Use Only.
IMU-935 (Izumerogant, IMU935, IM105935) is a potent, selective and orally available inverse agonist of retinoic acid-related orphan receptor gamma (RORγt) with IC50 of 24 nM.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥2580 | In stock | |
| 10 mg | ¥3980 | In stock | |
| 25 mg | ¥5980 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IMU-935 (Izumerogant, IMU935, IM105935) is a potent, selective and orally available inverse agonist / inhibitor of retinoic acid-related orphan receptor gamma (RORγt) with IC50 of 24 nM.
IMU-935 is shown to be a DHODH Inhibitor with an IC50 of 240 nM.
IMU-935 demonstrates synergistic inhibition of the secretion of IL-17A, IL-17F and IFNγ with IC50 concentrations of 3-5 nM tested in stimulated human lymphocytes.
IMU-935 inhibits Th17 differentiation of murine cells (IC50=135 nM), and inhibits IL-17F production from stimulated human PBMCs with IC50 of 2-4 nM.
IMU-935 demonstrates a strong inhibition of GM-CSF, IL-17A, IL-17F and IL-22 in inflamed human skin model (skin punches from human healthy volunteers).
IMU-935 inhibits Th17 differentiation and reduced EAE severity without affecting thymocyte development by selectively targeting the RORγt-CBFβ interaction in Th17 cells but not in thymocytes.
| 分子量 | 495.86 | |
| 分子式 | C22H18ClF4N5O2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
4-(4-(3-(2-chloro-6-fluorophenyl)-4-(pyrimidin-2-yl)isoxazol-5-yl)-5-(trifluoromethyl)-1H-pyrazol-1-yl)-2-methylbutan-2-ol |
|
1. Patent WO2019048541. 2019-03-14.
2. Wu H, et al. J Clin Invest. 2026 Jan 2;136(1):e185942.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright